Essential Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$348K Buy
2,668
+1,549
+138% +$232K 0.16% 127
2026
Q2
$170K Buy
1,119
+615
+122% +$102K 0.08% 278
2026
Q1
$106K Buy
504
+499
+9,980% +$125K 0.04% 413
2025
Q4
$1.42K Sell
5
-49
-91% -$15.3K ﹤0.01% 1913
2025
Q3
$16.7K Buy
54
+51
+1,700% +$16K 0.01% 954
2025
Q2
$943 Buy
+3
New +$866 ﹤0.01% 1531

Other funds holding PODD

Essential Partners's PODD Position: Q3 2026 in Review

Essential Partners increased its Insulet (PODD) stake by 138% in Q3 2026, buying an estimated $232K and bringing the position to 2,668 shares worth $348K. The position accounts for 0.16% of the portfolio, ranked #127.

Essential Partners first reported a position in PODD in Q2 2025 and has held it in 6 quarters since. 77 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • Essential Partners held 2,668 shares of Insulet worth $348K as of Q3 2026.
  • Essential Partners bought 1,549 Insulet shares in Q3 2026, an estimated $232K.
  • Insulet made up 0.16% of Essential Partners's portfolio in Q3 2026, its #127 holding.
  • Essential Partners first reported a position in Insulet in Q2 2025 and has held it in 6 quarters since.
  • 77 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.